Imagen de Portada

Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus

Background: The bile acid sequestrant colesevelam has been shown to significantly reduce low-density lipoprotein particle concentration (LDL-P) in adults with primary hyperlipidemia or type 2 diabetes mellitus (T2DM). Objective: To assess the effect of initial combination therapy with metformin plus...

Descripción completa

Detalles Bibliográficos
Autores Principales: Goldberg, Ronald B., Rosenson, Robert S., Hernandez-Triana, Eric, Misir, Soamnauth, Jones, Michael R.
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: 2012
Materias:
Apolipoprotein B
Chylomicron
Colesevelam
Hemoglobin a1c
High density lipoprotein cholesterol
Lipoprotein
Low density lipoprotein cholesterol
Metformin
Placebo
Triacylglycerol
Very low density lipoprotein
Adult
Article
Cholesterol blood level
Controlled study
Correlational study
Double blind procedure
Drug dose increase
Drug dose titration
Drug efficacy
Evening dosage
Female
Hemoglobin blood level
Human
Lipoprotein blood level
Major clinical study
Male
Morning dosage
Multicenter study
Non insulin dependent diabetes mellitus
Open study
Priority journal
Randomized controlled trial
Treatment duration
Triacylglycerol blood level
Allylamine
Anticholesteremic Agents
Apolipoprotein A-I
Apolipoproteins B
Double-Blind Method
Drug Administration Schedule
Humans
Hyperlipidemias
Middle Aged
Placebo Effect
Triglycerides
Apolipoprotein
Bile acid sequestrant
Lipoprotein particles
Low-density lipoprotein
Type 2 diabetes mellitus
Type 2
LDL
HDL
Glycosylated
Combination
Cholesterol
Diabetes Mellitus
Drug Therapy
Hemoglobin A
Lipoproteins
Acceso en línea:https://repository.urosario.edu.co/handle/10336/22299
https://doi.org/10.1016/j.jacl.2012.05.005

Internet

https://repository.urosario.edu.co/handle/10336/22299
https://doi.org/10.1016/j.jacl.2012.05.005

Ejemplares similares